Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HL
Clinical trial NCT03766516 · COMPLETED
Trial details
- NCT number
- NCT03766516
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-01
- Primary completion
- 2021-12-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.